Zobrazeno 1 - 10
of 79
pro vyhledávání: '"Clair E. Cox"'
Publikováno v:
Urology. 107:82-85
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cee3d4379b53bd25360ccb55315f7bf4
https://doi.org/10.1016/j.urology.2017.04.031
https://doi.org/10.1016/j.urology.2017.04.031
Publikováno v:
Journal of Urology. 199
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::15f290a4edccdc54230acb5e88948668
https://doi.org/10.1016/j.juro.2018.02.3036
https://doi.org/10.1016/j.juro.2018.02.3036
Publikováno v:
World Journal of Surgery. 25:1561-1564
The advent of noninvasive computed tomography of the abdomen and pelvis for evaluation of blunt renal trauma has led to the practice of expectant management for hemodynamically stable patients. Although expectant management of higher grade injuries (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bad997db0a54b6983efc27139245855
https://doi.org/10.1007/s00268-001-0150-0
https://doi.org/10.1007/s00268-001-0150-0
Autor:
Ira W. Klimberg, Edward Whalen, Clair E. Cox, Anthony Patterson, Steven F. Kowalsky, Gholam H. Malek, Roger Echols
Publikováno v:
Journal of Antimicrobial Chemotherapy. 43:77-84
To determine the efficacy and safety of single-dose oral ciprofloxacin prophylaxis for the prevention of post-operative bacteriuria following transurethral resection of the prostate or bladder tumour, a prospective, randomized, double-blind, placebo-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9c0391d0be856014adba0eca2a4a58d3
https://doi.org/10.1093/jac/43.suppl_1.77
https://doi.org/10.1093/jac/43.suppl_1.77
Autor:
Clair E. Cox
Publikováno v:
Infectious Diseases in Clinical Practice. 7:S126-s132
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ee688233ac499ab5af945593cd88df97
https://doi.org/10.1097/00019048-199809000-00004
https://doi.org/10.1097/00019048-199809000-00004
Autor:
Joan E. Fredericks, Leon C. Hamrick, Stacy J. Childs, David Pizzuti, Clair E. Cox, Jim O. Moon, Walter Pittman, James Clark, Patricia St. Clair
Publikováno v:
The American Journal of Medicine. 94:101S-104S
Patients were entered in a double-blind, placebo-controlled, multicenter study to compare low- and high-dose fleroxacin with norfloxacin for the treatment of complicated urinary tract infection (UTI). A total of 296 patients were enrolled; 102, 97, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::76dc4d42dfb9d30d7e828ed63e4eaa07
https://doi.org/10.1016/s0002-9343(20)31147-5
https://doi.org/10.1016/s0002-9343(20)31147-5
Autor:
Clair E. Cox
Publikováno v:
The American Journal of Medicine. 94:118S-125S
Intravenous fleroxacin, 400 mg once daily, was compared with intravenous ceftazidime, 0.5–2 g three times a day or 1–2 g twice a day, administered for 4–21 days for treatment of complicated urinary tract infections (UTIs) due to susceptible org
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::02f94013803f388873d1c3556e08cce4
https://doi.org/10.1016/s0002-9343(20)31151-7
https://doi.org/10.1016/s0002-9343(20)31151-7
Autor:
Clair E. Cox, George Adams, Howard Epstein, Keith Lloyd, Ira Klimberg, Herbert Lepor, Atul R. Laddu
Publikováno v:
Southern Medical Journal. 85:3S-109
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::303d9b51ac41b590c26e50d247e3d9a0
https://doi.org/10.1097/00007611-199209001-00320
https://doi.org/10.1097/00007611-199209001-00320
Publikováno v:
Urology. 39:453-456
The efficacy and safety of parenteral ofloxacin were evaluated in an open, multicenter study of hospitalized patients with pyelonephritis. The patients received ofloxacin 400 mg IV as an initial dose followed by ofloxacin 200 mg IV b.i.d. for a minim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2c48266b03de396fa60515fd026f580
https://doi.org/10.1016/0090-4295(92)90246-s
https://doi.org/10.1016/0090-4295(92)90246-s
Autor:
Clair E. Cox
Publikováno v:
The American Journal of Medicine. 91:S129-S133
Temafloxacin is a new oral fluoroquinolone with broad-spectrum antimicrobial activity against gram-negative and gram-positive pathogens. The safety and efficacy of temafloxacin were evaluated in a multicenter, double-blind study of patients with comp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::116db60b3cb3ee6b2068cdd4eb0d78b9
https://doi.org/10.1016/0002-9343(91)90325-r
https://doi.org/10.1016/0002-9343(91)90325-r